ARCHIVES

NCI To Require Reports On Adverse Drug Reactions From Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

Enzalutamide Reduced Risk of Progression By 81 Percent in Metastatic Prostate Cancer

June 27, 2014

Funding opportunities listed.

February 20, 2004

In Brief: French 10 Years Behind In Treatment Techniques, Rauscher Tells Premier; European Interest Grows

September 26, 1975

I-ELCAP Results Internally Inconsistent, Peter Bach Writes

June 24, 2011

NIH-funded HapMap consortium publishes first phase of catalog.

October 28, 2005

Clinical Trials Approved By NCI CTEP Last Month

July 29, 2011